MERLIN
LIVE

Serial Number

79303109

Owner

SKYLINEDX, B.V.

Attorney

James C. Watson

Filing Date

Oct 26, 2020

Add to watchlist:

No watchlists yet
View on USPTO

MERLIN Trademark

Serial Number: 79303109 • Registration: 6549735

MERLIN is a trademark filed by SKYLINEDX, B.V. on October 26, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

SKYLINEDX, B.V. (6 trademarks)

ROTTERDAM SCIENCE TOWER
AK ROTTERDAM 3029 , NL

Entity Type: 26

Trademark Details

Filing Date

October 26, 2020

Registration Date

November 9, 2021

Published for Opposition

August 24, 2021

Goods & Services

Medical analysis services for diagnostic and treatment-decision purposes provided by medical laboratories; medical analysis services for diagnostic and treatment-decision purposes provided by medical laboratories using test scores and data for medical or veterinary purposes for others; medical and veterinary information services provided via the internet; medical testing for diagnostic or treatment purposes; medical diagnostic testing, monitoring and reporting services; medical analysis services for cancer diagnosis and prognosis; medical services for the treatment of skin cancer; medical analysis services for the diagnosis of cancer

Medical molecular diagnostic test reagents; medical molecular diagnostic test reagents of body substances, such as bone marrow samples, blood samples, and on human or animal tissue; molecular diagnostic test reagents for cancer for medical purposes; medical molecular diagnostic test reagents, inter alia on the basis of microarray technology and sequencing technology; reagents for use in medical genetic testing; reagents for use in medical genetic testing for the measurement of the gene expression profile; reagents for use in medical genetic testing for the measurement of gene aberrations and mutations; clinical diagnostic test reagents for determination of genetic sub-type of a patient; medical prognostic test reagents for testing of bodily fluids for use in disease detection, namely oncology; predictive test reagents, in search of the effectiveness of a medical treatment and/or to select the medical treatment; diagnostic test reagents and preparations for medical or veterinary purposes; chemical preparations, for medical purposes, for the testing of blood and human or animal tissue, including cancer cells; medical diagnostic test strips for tissue-based diagnostics; diagnostic testing materials for medical use, namely medical diagnostic reagents and assays for testing of tissue for use in disease detection, namely oncology; preparations for detecting mutation in human genes for medical purposes

Research and development of new products for others; biochemical research and development; pharmaceutical research and development; research and development in the field of diagnostic preparations; biological research, clinical research provided via a website and medical research; scientific research for the benefit of the development of molecular diagnostic tests; analysis and evaluation of results from quality control tests of the goods of others to determine conformity with certification standards; molecular diagnostic analysis; investigation and analysis of body substances and molecular diagnostic test scores for the purpose of the development of new biomarkers; development and diagnostic testing of treatment methods for scientific research for medical purposes; development and testing services for the certification of quality or standards of molecular diagnostic tests; computer aided diagnostic testing services for others in the fields of science and research related thereto; scientific research for medical purposes in the area of cancerous diseases; genetic testing for scientific research purposes; research of pharmaceutical preparations in the field of gene therapy; providing information about medical research in the field of diagnostic testing services in the field of skin cancer

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
May 24, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 1, 2022 FICS
FINAL DISPOSITION PROCESSED
May 1, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 9, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 9, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 24, 2021 NPUB
PUBLISHED FOR OPPOSITION
Aug 24, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Aug 22, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 4, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 4, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 4, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 16, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 9, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 8, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 8, 2021 TROA
REFUSAL PROCESSED BY IB
Apr 25, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 6, 2021 RFCS
REFUSAL PROCESSED BY MPU
Apr 6, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 31, 2021 RFCR
NON-FINAL ACTION WRITTEN
Mar 30, 2021 CNRT
ASSIGNED TO EXAMINER
Mar 26, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 2, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 29, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 28, 2021 REPR